← 返回 Skills 市场
Curevac
作者
hanxueyuan
· GitHub ↗
· v1.0.0
· MIT-0
85
总下载
0
收藏
1
当前安装
1
版本数
在 OpenClaw 中安装
/install curevac
功能描述
CureVac is a German mRNA pioneer focusing on vaccines, cancer immunotherapy, and rare diseases, partnered with GSK for advanced clinical development.
使用说明 (SKILL.md)
CureVac — 德国 mRNA 先驱
历史时间线
- 2000: 从德国蒂宾根大学孵化成立
- 2001: 发现 mRNA 可以用于蛋白质治疗
- 2006: 首次证明 mRNA 可以用于疫苗开发
- 2014: 获 GSK 投资
- 2020: 新冠疫苗竞赛中与 BioNTech/Moderna 竞争
- 2021: 疫苗临床试验结果不如预期
- 2022: 战略转型，聚焦肿瘤免疫和罕见病
- 2023: 与 GSK 合作开发 mRNA 流感疫苗
商业模式
mRNA 疗法 + 疫苗开发。从新冠疫苗转向肿瘤免疫和罕见病治疗。与 GSK 的合作关系是核心竞争力。
护城河分析
mRNA 技术的先发优势——比 BioNTech 和 Moderna 更早开始研究。与 GSK 的战略合作加速了临床开发。在肿瘤 mRNA 免疫治疗领域的独特布局。
关键数据
- 2020 年 IPO 融资 €1.6 亿
- 与 GSK 的 mRNA 合作价值超 $30 亿
- 员工约 700 人
- 在肿瘤和罕见病领域有 10+ 个管线
有趣事实
CureVac 的创始人 Ingmar Hoerr 在 2000 年发现，如果把裸 mRNA 注射到小鼠体内，小鼠会产生免疫反应——这个发现后来成为了 mRNA 疫苗的理论基础。但他花了 20 年才让这个想法变成现实。
安全使用建议
This skill appears low-risk and coherent with its stated purpose — it's a static company profile with no code, installs, or credential needs. Consider whether you trust the unknown source (no homepage provided) and whether you need up-to-date or authoritative data: verify important facts against primary sources (company filings, official press releases, peer-reviewed literature) before using the information for critical decisions. If provenance matters to you, prefer skills with a known homepage or verifiable publisher.
功能分析
Type: OpenClaw Skill
Name: curevac
Version: 1.0.0
The skill bundle contains purely informational content regarding the history, business model, and market position of CureVac. There are no executable code blocks, shell commands, network requests, or prompt injection attempts in SKILL.md or _meta.json.
能力评估
Purpose & Capability
Name and description match the SKILL.md content (company history, business, technical context). The skill declares no binaries, env vars, or config paths — which is appropriate for an informational company profile.
Instruction Scope
SKILL.md contains only topical guidance (when to read/what to research) and static informational content. It does not instruct the agent to read local files, access credentials, call external endpoints, or exfiltrate data.
Install Mechanism
No install specification and no code files are present, so nothing is written to disk or executed during install — lowest-risk model.
Credentials
The skill requests no environment variables, secrets, or config paths; there is no disproportionate credential access.
Persistence & Privilege
always is false and the skill is user-invocable. Model invocation is allowed (platform default), which is normal for a read-only informational skill and not concerning by itself.
如何使用
- 确保已安装 OpenClaw（本地或 Docker 部署）
- 在对话框中输入安装命令：
/install curevac - 安装完成后，直接呼叫该 Skill 的名称或使用
/curevac触发 - 根据 Skill 的参数说明提供必要输入，即可获得结构化输出
版本历史
v1.0.0
CureVac skill v1.0.0
- Introduces a comprehensive overview of CureVac's history, milestones, and business model.
- Highlights CureVac's competition with BioNTech and Moderna in the mRNA vaccine race.
- Explains the company's strategic shift towards oncology and rare disease applications.
- Features key partnerships, especially with GSK, and their impact on CureVac's growth.
- Includes notable facts and milestone data for context and reference.
元数据
常见问题
Curevac 是什么？
CureVac is a German mRNA pioneer focusing on vaccines, cancer immunotherapy, and rare diseases, partnered with GSK for advanced clinical development. 它是一个面向 Claude Code / OpenClaw 的 AI Agent Skill 插件，目前累计下载 85 次。
如何安装 Curevac？
在 OpenClaw 或 Claude Code 对话框中运行命令「/install curevac」即可一键安装，无需额外配置。
Curevac 是免费的吗？
是的，Curevac 完全免费，采用 MIT-0 许可证，可自由下载、安装和使用。
Curevac 支持哪些平台？
Curevac 跨平台运行，可在任意部署了 OpenClaw / Claude Code 的环境中使用（cross-platform）。
谁开发了 Curevac？
由 hanxueyuan（@hanxueyuan）开发并维护，当前版本 v1.0.0。
推荐 Skills